Tampa Associating Microwave Liver Ablation With Portal Vein Ligation for Staged Hepatectomy (TAMLAPS)

Complete Robotic Tampa Associating Microwave Liver Ablation With Portal Vein Ligation

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03739164

Acronym

TAMLAPS

Enrollment

Registered

2018-11-13

Start date

2018-07-18

Completion date

2024-12-31

Last updated

2018-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatocellular Carcinoma, Hilar Cholangiocarcinoma, Liver Cancer, Liver Tumor

Brief summary

This is a study following the outcomes and survival of patients undergoing the TAMLAPS hepatectomy at Florida Hospital Tampa by Dr. Iswanto Sucandy

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 80 Years

Healthy volunteers

Inclusion criteria

* Patients scheduled to undergo the TAMLAPS procedure by Dr. Iswanto Sucandy.

Exclusion criteria

* Subjects with history of noncompliance. * Subjects with physical health, substance abuse, or mental health problems that will limit the subject's ability to meet study requirements

Design outcomes

Primary

Measure	Time frame	Description
Growth of the Future Liver remnant	2 weeks	1\. Liver growth determined by measuring the kinetic growth rate obtained from pre-operative and post-op stage one CT evaluations of the FLR volume

Countries

United States

Outcome results